(20 days)
Not Found
No
The device description focuses on the chemical composition and physical properties of bone cement, with no mention of AI or ML.
Yes
The device, CEMEX bone cement, is intended for the fixation of plastic and metal joint prostheses to host bone, which is a therapeutic purpose to treat various orthopedic conditions.
No
The Intended Use and Indications for Use sections describe the device as a bone cement for fixing prostheses, which is a therapeutic rather than a diagnostic function.
No
The device description clearly outlines chemical constituents and physical properties of a bone cement, which is a physical material, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the "fixation of plastic and metal joint prostheses to host bone." This is a surgical procedure performed directly on the patient's body.
- Device Description: The device is a bone cement, a material used to physically attach implants to bone.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or treatment.
IVD devices are used in vitro (outside the body) to analyze samples. This bone cement is used in vivo (inside the body) during surgery.
N/A
Intended Use / Indications for Use
CEMEX RX, CEMEX ISOPLASTIC and CEMEX XL bone cements are intended to be used for the fixation of plastic and metal joint prostheses to host bone.
CEMEX bone cement is indicated for the fixation of prostheses to bone in orthopaedic musculoskeletal procedures for osteoarthritis, rheumatoid arthritis, osteonecrosis, ankylosing spondylitis, tramatic arthritis, congenital deformities, avascular necrosis, post-traumatic degenerative problems of the joint, sickle cell anemia, osteoporosis, collagen disease and for the revision of previous arthroplasty procedures.
Product codes (comma separated list FDA assigned to the subject device)
LOD
Device Description
The chemical constituents in CEMEX RX, ISOPLASTIC, and XL bone cements are identical to those in the predicate CEMEX SYSTEM cement (#K000943). The liquid component contains methylmethacrylate, N-N dimethyl p-toluidine, and hydroquinone. The dry powder component contains polymethylmethacrylate, barium sulphate and benzoyl peroxide. Like the predicate CEMEX SYSTEM Bone Cement (#K000943), the ratio between the powder and liquid components of the proposed cements is 3:1.
The proportion of each ingredient in the ISOPLASTIC and RX models varies slightly from the predicate model. The XL bone cement formulation is identical to that of CEMEX SYSTEM (#K000943). The differences result in a range of viscosities to accommodate various application techniques.
The liquid monomer component is contained in a trumpet shaped amber glass vial. The powder component is contained in a paper polyethylene (PE) film sachet. The product is packaged in unitary blister pack with Tyvek® lids. The outer packaging is a heavy weight cardboard box.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3027 Polymethylmethacrylate (PMMA) bone cement.
(a)
Identification. Polymethylmethacrylate (PMMA) bone cement is a device intended to be implanted that is made from methylmethacrylate, polymethylmethacrylate, esters of methacrylic acid, or copolymers containing polymethylmethacrylate and polystyrene. The device is intended for use in arthroplastic procedures of the hip, knee, and other joints for the fixation of polymer or metallic prosthetic implants to living bone.(b)
Classification. Class II (special controls). The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Polymethylmethacrylate (PMMA) Bone Cement.”
0
JUN 1 2 2002
Exactech, Inc. Tecres Cemex® System Bone Cement
page 1 of 2
K021715
Special 510(k) Summary of Safety and Effectiveness
| Trade Names: | Cemex ISOPLASTIC Bone Cement
Cemex RX Bone Cement
Cemex XL Bone Cement |
|----------------------|------------------------------------------------------------------------------|
| Common Name: | Bone Cement |
| Classification Name: | Polymethylmethacrylate (PMMA)
Bone Cement |
Legally Marketed Devices for Substantial Equivalence Comparison:
| Model | Manufacturer |
|---|---|
| Cemex System | Tecres, S.p.A. (#K000943) |
| CMW3 | CMW Laboratories |
| (Distributed by Dow Corning Wright | |
| Simplex P | Howmedica |
| Palacos R | Merck |
| (Distributed by Smith & Nephew) | |
| Dough-Type | Zimmer |
Device Description:
INTENDED USE
CEMEX RX, CEMEX ISOPLASTIC and CEMEX XL bone cements are intended to be used for the fixation of plastic and metal joint prostheses to host bone.
INDICATIONS FOR USE
CEMEX bone cement is indicated for the fixation of prostheses to bone in orthopaedic musculoskeletal procedures for osteoarthritis, rheumatoid arthritis, osteonecrosis, ankylosing spondylitis, tramatic arthritis, congenital deformities, avascular necrosis, post-traumatic degenerative problems of the joint, sickle cell anemia, osteoporosis, collagen disease and for the revision of previous arthroplasty procedures.
Section 4 Page 2 of 3
1
Exactech, Inc. Tecres Cemex® System Bone Cement
page 2 of 2
K021715
Special 510(k) Summary of Safety and Effectiveness
CONTRAINDICATIONS
CEMEX bone cement is contraindicated in the presence of active or incompletely treated infection which could involve the site where the cement is to be applied. CEMEX bone cement is contraindicated where the loss of musculature or neuromuscular compromise in the affected limb would render the surgical procedure unjustifiable. CEMEX bone cement is contraindicated in patients who are allergic to any of its components.
GENERAL DESCRIPTION - Substantial Equivalency Information
The chemical constituents in CEMEX RX, ISOPLASTIC, and XL bone cements are identical to those in the predicate CEMEX SYSTEM cement (#K000943). The liquid component contains methylmethacrylate, N-N dimethyl p-toluidine, and hydroquinone. The dry powder component contains polymethylmethacrylate, barium sulphate and benzoyl peroxide. Like the predicate CEMEX SYSTEM Bone Cement (#K000943), the ratio between the powder and liquid components of the proposed cements is 3:1.
The proportion of each ingredient in the ISOPLASTIC and RX models varies slightly from the predicate model. The XL bone cement formulation is identical to that of CEMEX SYSTEM (#K000943). The differences result in a range of viscosities to accommodate various application techniques.
Cemex XL. RX and ISO bone cements are also similar to other competitive cement products including "Simplex P" by Howmedica, "CMW 3" by Dow Corning Wright, "Dough" by Zimmer, and "Palacos R" by Smith & Nephew. Several of the predicate devices are indicated for the fixation of pathological fractures but Cemex bone cements are not indicated for this application.
PACKAGING
The liquid monomer component is contained in a trumpet shaped amber glass vial. The powder component is contained in a paper polyethylene (PE) film sachet. The product is packaged in unitary blister pack with Tyvek® lids. The outer packaging is a heavy weight cardboard box.
STERILITY ASSURANCE
The powdered component is sterilized by ethylene oxide (EO) to a Sterility Assurance Level (SAL) of 10°. The liquid component is sterilized by a membrane filtration technique to a SAL of 10-3.
Section 4 Page 3 of 3
2
Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal is circular and contains the department's name around the perimeter. In the center of the seal is a stylized caduceus, a symbol often associated with medicine and healthcare. The caduceus consists of a staff with two snakes coiled around it.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 1 2 2002
Ms. Lisa Simpson Regulatory Representative Exactech® 2320 NW 66th Court Gainesville, Fl 32653
Re: K021715
Trade Name: Tecres Bone Cement RX, ISOPLASTIC, XL Regulation Number: 21 CFR 888.3027 Regulation Name: PolymethyImethacrylate (PMMA) bone cement Regulatory Class: II Product Code: LOD Dated: May 22, 2002 Received: May 23, 2002
Dear Ms. Simpson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Ms. Lisa Simpson
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Mach N Millkern
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Tecres Cemex Bone Cement
Indications for Use
page iofl
ON1715 510(k) Number:
. Device Names:
Cemex Rx Bone Cement Cemex XL Bone Cement Cemex Isoplastic Bone Cement
INTENDED USE
CEMEX bone cement is intended to be used for the fixation of artificial joint prostheses to the host bone.
INDICATIONS FOR USE
CEMEX bone cement is indicated for the fixation of protheses to bone in orthopaedic musculoskeletal procedures for osteoarthritis, rheumatoid arthritis, osteonecrosis, ankylosing spondylitis, tramatic arthritis, congenital deformities, avascular necrosis, post-traumatic degenerative problems of the joint, sickle cell anemia, osteoporosis, collagen disease and for the revision of previous arthroplasty procedures.
CONTRAINDICATIONS
CEMEX bone cement is contraindicated in the presence of active or incompletely treated infection which could involve the site where the cement is to be applied.
CEMEX bone cement is contraindicated where the loss of musculature or neuromuscular compromise in the affected limb would render the surgical procedure unjustifiable.
CEMEX bone cement is contraindicated in patients who are allergic to any of its components
Please do not write below this line - use another page if needed.
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use | or | Over the Counter Use |
|---|---|---|
| ------------------ | ---- | ---------------------- |
for Mark A Millbern
(Division Sign-Off)
Division of General, Restorative
and Neurological Devices
| 510(k) Number | K021715 |
|---|---|
| Section 3 | |
| Page 1 of 1 |